QuidelOrtho Corporation (QDEL) Actualités

Form 8-K - Current report

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

Veteran Healthcare CEOs John R. Chiminski and R. Scott Huennekens Bring Deep Industry Experience, Operational...

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Form 424B3 - Prospectus [Rule 424(b)(3)]

QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies...

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies...

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Form 8-K - Current report

Form 8-K/A - Current report: [Amend]

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm PR Newswire NEW YORK, Nov. 13...

Form 8-K - Current report

Form 8-K - Current report

QuidelOrtho Reports Third Quarter 2024 Financial Results

― Company reinstates 2024 financial guidance ― ― Drives cost-savings and growth initiatives ― ― Strengthens leadership team and aligns...